Dr. William Morice
Contributor
William Morice II, M.D., Ph.D., is the president and chief executive officer of Mayo Clinic’s diagnostic business lines, which include Mayo Clinic Laboratories and Mayo Clinic’s Cardiac Monitoring. Mayo Clinic Laboratories is the global leader in turning test results into clinical answers by providing advanced testing and pathology services for healthcare organizations in partnership with Mayo Clinic’s Department of Laboratory Medicine and Pathology. Dr. Morice served as the chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, from 2015 to 2022. He is a consultant in the Division of Hematopathology and served as the chair of this division from 2009 to 2015.
He holds the academic rank of professor of laboratory medicine and pathology in the Mayo Clinic College of Medicine and Science. As an expert in diagnostic hematopathology, flow cytometry, and T and NK cell biology, among other topics, Dr. Morice is sought after as a national and international lecturer and visiting professor.
Additionally, as an active educator and mentor, Dr. Morice teaches residents, fellows, and allied health staff the analytic approach to the diagnosis of benign and malignant hematolymphoid disorders. He has written more than 160 peer-reviewed articles, book chapters, and abstracts. Dr. Morice received his Bachelor of Science degree in biochemistry from Indiana University and earned his M.D./Ph.D. (immunology) degrees from the Mayo Clinic Graduate School of Biomedical Sciences. Dr. Morice completed a preliminary residency year in internal medicine, a combined residency program in anatomic pathology and clinical pathology, and fellowships in surgical pathology and hematopathology, all at the Mayo Clinic School of Graduate Medical Education. He currently serves as president and board chair of the American Clinical Laboratory Association.
Recent Articles
